Celldex Therapeutics Stock (NASDAQ: CLDX) stock price, news, charts, stock research, profile.
You can purchase shares of Celldex Therapeutics (NASDAQ:CLDX) through any online brokerage.
Other companies in Celldex Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), Xencor (NASDAQ:XNCR), Kiniksa Pharmaceuticals (NASDAQ:KNSA) and Bicycle Therapeutics (NASDAQ:BCYC).
Celldex Therapeutics has a consensus price target of $65.75.
The stock price for Celldex Therapeutics (NASDAQ: CLDX) is $26.06 last updated October 31, 2024 at 4:56 PM EDT.
There are no upcoming dividends for Celldex Therapeutics.
Celldex Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Celldex Therapeutics.
Celldex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.